No Data
No Data
Express News | SUNZEN Reports FY25Q1 Revenue of RM22.96 Million
Sunzen Biotech Bhd Malaysia 1st-Quarter 2024 Earnings Summary Table
SUNZEN: Quarterly rpt on consolidated results for the financial period ended 30/09/2024
Sunzen Biotech Identifies Another Target for Acquisition, Deal May Be Reached Next Year
MISC, MHB, PA Resources, Tanco, Ho Hup, Central Global, Sunzen Biotech, Aemulus, Pharmaniaga, Plenitude, Pasdec
Sunzen Biotech Expands Into Ophthalmic Industry With Eye Nation Medical Stake Acquisition
No Data
No Data
TheTruth OP : No wonder.. It's share buyback